Oxidation sensitivity may be a useful tool for the detection of the hematotoxic potential of newly developed molecules: Application to antipsychotic drugs

Archives of Biochemistry and Biophysics

Volumn 370, Issue 1, 1999, Pages 126-137

  Liégeois, Jean François ^a   Bruhwyler, Jacques ^b   Petit, Christine ^c   Damas, Jacques ^a   Delarge, Jacques ^a   Géczy, Joseph ^b   Kauffmann, Jean Michel ^c   Lamy, Maurice ^a   Meltzer, Herbert ^d   Mouithys Mickalad, Ange ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Therabel Pharma Belgium   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Agranulocytosis; Antipsychotic; Clozapine; Oxidation; Predictiv e model; Pyridobenzazepine

Indexed keywords

BENZAZEPINE DERIVATIVE; CLOZAPINE; FLUPERLAPINE; FREE RADICAL; NEUROLEPTIC AGENT; PEROXIDASE; THIAZEPINE DERIVATIVE;

AGRANULOCYTOSIS; APLASTIC ANEMIA; ARTICLE; BLOOD TOXICITY; DRUG CLASSIFICATION; DRUG DISCRIMINATION; DRUG STRUCTURE; HUMAN; LIPID PEROXIDATION; MODEL; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL;

EID: 0342280928     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1999.1380     Document Type: Article

References (77)

1. Bruhwyler J., Chleide E., Mercier M. Neurosci. Biobehav. Rev. 14:1990;357-363.
2. Pirmohamed M., Park K. CNS Drugs. 7:1997;139-158.
3. Laidlaw S. T., Snowden J. A., Brown M. J. Lancet. 342:1993;1245.
4. Philpott N. J., Marsh J. C., Gordon-Smith E. C., Bolton J. S. Lancet. 342:1993;1244-1245.
5. Kane J., Honigfeld G., Singer J., Meltzer H. Y. Arch. Gen. Psychiatry. 45:1988;789-796.
6. Alvir J. M., Lieberman J. A. J. Clin. Psychiatry. 55:1994;137-138.
7. Beasley C. M., Tollefson G. D., Tran P. V. J. Clin. Psychiatry. 58:1997;13-17.
8. Casey D. E. J. Clin. Psychiatry. 58:1997;55-62.
9. Gardner I., Leeder J. S., Chin T., Zahid N., Uetrecht J. P. Mol. Pharmacol. 53:1998;999-1008.
10. Gardner, I., Zahid, N., McCrimmon, D., and Uetrecht, J. P.Mol. Pharmacol.53, 991-998.
11. Livingston M. G. Lancet. 343:1994;457-460.
12. Gerlach J., Peacock L. Int. Clin. Psychopharmacol. 10:1995;39-48.
13. Casey D. E. J. Clin. Psychiatry. 57:1996;40-45.
14. Brown G. R., Radford J. South Med. J. 90:1997;691-693.
15. Casey D. E. Br. J. Psychiatry. S29:1996;32-39.
16. Daniel D. G., Goldberg T. E., Weinberger D. R., Kleinman J. E., Pickar D., Lubick L. J., Williams T. S. Am. J. Psychiatry. 153:1996;417-419.
17. Werapongset W., Chaisirikul S., Chrujiporn W., Visanuyothin T., Kessawai D., Charisilp C., Ratanachata N., Sanichwannakul K., Wangdee P., Bunditchate A., Ukranand P. J. Med. Assoc. Thailand. 81:1998;324-328.
18. Fulton B., Goa K. L. Drugs. 53:1997;281-298.
19. Bruhwyler J., Liégeois J.-F., Chleide E., Rogister F., Damas J., Delarge J., Mercier M. Behav. Pharmacol. 3:1992;567-579.
20. Liégeois J.-F., Bruhwyler J., Damas J., Nguyen T. P., Chleide E., Mercier M., Rogister F., Delarge J. J. Med. Chem. 36:1993;2107-2114.
21. Liégeois J.-F., Rogister F., Bruhwyler J., Damas J., Nguyen T. P., Inarejos M. O., Chleide E., Mercier M., Delarge J. J. Med. Chem. 37:1994;519-525.
22. Liégeois, J.-F, and, Delarge, J. 1995, US Patent 5.393.752.
23. Bruhwyler J., Liégeois J.-F., Bergman J., Carey G., Goudie A., Taylor A., Meltzer H. Y., Delarge J., Géczy J. Pharmacol. Res. 36:1997;255-264.
24. Guest J., Sokoluk B., MacCrimmon J., Uetrecht J. Toxicol. 131:1998;53-65.
25. Vincent P. C. Drugs. 31:1986;52-63.
26. Pisciotta A. V. Blood Rev. 4:1990;226-237.
27. Uetrecht J. P., Zahid N., Tehim A., Mimfu J., Rakhit S. Chem.-Biol. Interact. 104:1997;117-129.
28. Gerson S. L., Meltzer H. Y. Drug Safety. 7:1992;17-25.
29. Gerson S. L. New Engl. J. Med. 329:1993;204-205.
30. Veys P. A., Wilkes S., Shah S., Noyelle R., Hoffbrand A. V. Drug Safety. 7:1992;26-32.
31. Fischer V., Haar J. A., Greiner L., Lloyd R. V., Mason R. P. Mol. Pharmacol. 40:1991;846-853.
32. Maggs J. L., Williams D., Pirmohamed M., Park B. K. J. Pharmacol. Exp. Ther. 275:1995;1463-1475.
33. Pirmohamed M., Williams D., Madden S., Templeton E., Park B. K. J. Pharmacol. Exp. Ther. 272:1995;984-990.
34. Liu Z. C., Uetrecht J. J. Pharmacol. Exp. Ther. 275:1995;1476-1483.
35. Uetrecht J. P. Eur. J. Haematol. 57:1996;83-88.
36. Linday L. A., Pippenger C. E., Howard A., Lerberman J. A. J. Clin. Psychopharmacol. 15:1995;353-360.
37. Abdalla D. S., Monteiro H. P., Oliveira J. A., Bechara E. J. Clin. Chem. 32:1986;805-807.
38. Liégeois J.-F., Rogister F., Delarge J., Pincemail J. Arch. Pharm. 328:1995;109-112.
39. Liégeois J.-F., Mouithys-Mickalad A., Bruhwyler J., Delarge J., Petit C., Kauffmann J.-M., Lamy M. Biochem. Biophys. Res. Commun. 238:1997;252-255.
40. Munyon W. H., Salo R., Briones D. F. Psychopharmacology. 91:1987;182-188.
41. Cunningham Owens D. G. Drugs. 51:1996;895-930.
42. van der Klauw M., Wilson J. H. P., Stricker B. H. C. Am. J. Hematol. 57:1998;206-211.
43. Reynolds J. E. F. Martindale, the Extra Pharmacopoiea. 1989;Pharmaceutical Press, London.
44. Green M. J., Hill A. O. Packer L. Methods in Enzymology, Vol 105, Oxygen Radicals in Biological Systems. 1984;3-22 Academic Press, London.
45. Walls R., Kumar K. S., Hochstein P. Arch. Biochem. Biophys. 174:1976;463-468.
46. Uetrecht J. P. Pharm. Res. 6:1989;265-273.
47. Kaufman D. W., Kelly J. P., Jurgelon J. M., Anderson T., Issaragrisil S., Wiholm B.-E., Young N. S., Leaverton P., Levy M., Shapiro S. Eur. J. Haematol. 57:1996;23-30.
48. Delannoy A., D'Hondt L., Pirson F. Louvain Médical. 111:1992;455-459.
49. Mason R. P., Fischer V. Drug Safety. 7:1992;45-50.
50. Casey D. E. Exp. Opin. Invest Drugs. 5:1996;939-957.
51. Flynn S. W., Altman S., McEwan G. W., Greenidge L. L., Honer W. G. J. Clin. Psychopharmacol. 17:1997;494-495.
52. Lambert T. Aust. New Zealand J. Psychiatry. 32:1998;591-592.
53. Wray C.-M., Sztuke-Fournier A. C. M. A. J. 159:1998;81-82.
54. Harman L. S., Carver D. K., Schreiber J., Mason R. P. J. Biol. Chem. 261:1986;1642-1648.
55. Petit C., Murakami K., Eerdema A., Kilinc E., Ortiz Borondo G., Liégeois J.-F., Kauffmann J.-M. Electroanalysis. 10:1998;1241-1248.
56. Uetrecht J. P., Zahid N., Shear N. H., Biggar W. D. J. Pharmacol. Exp. Ther. 245:1988;274-279.
57. Coleman M. D. Gen. Pharmacol. 26:1995;1461-1467.
58. Bever K. A., Perry P. J. Am. J. Health-System Pharm. 55:1998;1003-1016.
59. Finkel B., Lerner A., Oyffe I., Rudinski D., Sigal M., Weizman A. Int. Clin. Psychopharmacol. 13:1998;133-135.
60. Olesen O. V., Linnet K. J. Chromatogr. B. 714:1998;309-315.
61. Aravagiri K., Ames D., Wirshing W. C., Marder S. R. Ther. Drug Monit. 19:1997;307-313.
62. Weigmann H., Hiemke C. J. Chromatogr. 583:1992;209-216.
63. Kassahun K., Mattiuz E., Franklin R., Gillepsie T. Drug Metab. Disp. 26:1998;848-855.
64. Goudemand J., Plouvier J., Bauters F., Goudemand M. Semaine des Hôpitaux. 52:1976;1513-1520.
65. Von Muhlendahl K. E. Deutsche Med. Wochenschrift. 112:1987;158-159.
66. Lacotte J., Perrin C., Mosquet B., Moulin M., Bazin C. Thérapie. 45:1990;438-439.
67. Sharafuddin M. J., Spanheimer R. G., McClune G. L. Acta Haematol. 86:1991;212-213.
68. Rawanduzy A., Sarkis A., Rovit R. L. J. Surg. 79:1993;121-124.
69. Meunier G., Bernadou J., Meunier B. Biochem. Pharmacol. 36:1987;2599-2604.
70. Potter D. W., Hinson J. A. J. Biol. Chem. 262:1987;974-980.
71. Fischer V., Harman L. S., West P. R., Mason R. P. Chem.-Biol. Interact. 60:1986;115-127.
72. Guillouzou A., Begue J.-M., Maurer G., Koch P. Xenobiotica. 18:1988;131-139.
73. Parrish D. D., Schlosser M. J., Kapeghian J. C., Traina V. M. Fundam. Appl. Toxicol. 35:1997;197-204.
74. Ju C., Uetrecht J. P. Drug Metab. Dispos. 26:1998;676-680.
75. Pullen R. H., Palermo K. M., Curtis M. A. J. Chromatogr. Biomed. Appl. 573:1992;49-57.
76. Gerson S. L., Arce C., Meltzer H. Y. Br. J. Haematol. 86:1994;555-561.
77. Williams D. P., Pirmohamed M., Naisbitt D. J., Maggs J. L., Park B. K. J. Pharmacol. Exp. Ther. 283:1997;1375-1382.